HSPA5 and colorectal carcinoma: To further examine whether GRP78 indeed mediated the 5-Fu resistant acquired by TAMs-CM, we depleted GRP78 using two shRNAs (Fig. 2G), and further assessed the ability of TAM-CM to induce 5-FU resistance in CRC cells.